15.306 articles found

Clinical Insights on Caloric Restriction Mimetics for Mitigating Brain Aging and Related Neurodegeneration.

Trisal A, Singh AK.

Cell Mol Neurobiol · 2024-10-16

DOI: 10.1007/s10571-024-01493-2PMID: 39412683

"Ups and Downs, Joys and Sorrows" - Assessment and Clinical Relevance of Patient Priorities in an Interdisciplinary Parkinson's Disease Clinic.

Trahairv ED, Allen AM, Mantri S.

J Patient Cent Res Rev · 2024-10-15

DOI: 10.17294/2330-0698.2078PMID: 39439538

A case of argyrophilic grain disease with an initial clinical diagnosis of Parkinson's disease.

Arakawa A, Murayama S, Morimoto S, Matsubara T, Sengoku R, Kameyama M, Tokumaru AM, Tarutani A, Hasegawa M, Iwata A, Toda T, Saito Y.

J Neurol · 2024-10-15

DOI: 10.1007/s00415-024-12688-4PMID: 39402237

Complex Exercises Improve Cognition in People With Parkinson's Disease and Freezing of Gait.

Silva-Batista C, Almeida FO, Batista A, Barbosa ER, Horak FB, Ugrinowitsch C.

Neurorehabil Neural Repair · 2024-10-15

DOI: 10.1177/15459683241290793PMID: 39403970

Clinical Utility of Neurophysiologic Classification (and Declassification) of Myoclonus.

Callister MN, Klanderman MC, Stockard A, Van Der Walt C, Pena AB, Caviness JN.

Mov Disord · 2024-10-14

DOI: 10.1002/mds.30022PMID: 39400359

Effects of a sequential square mat walking training program Fisior® on improving physical performance in older adults with Parkinson's disease: A pilot study.

Alegre-Tamariz J, Runzer-Colmenares FM, Bermejo-Franco A, Parodi JF.

Geriatr Nurs · 2024-10-11

DOI: 10.1016/j.gerinurse.2024.09.021PMID: 39393306

Capturing Trial-by-Trial Variability in Behaviour: People with Parkinson’s Disease Exhibit a Greater Rate of Short-Term Fluctuations in Response Times

MacDonald HJ, Fasmer OB, Jønsi OT, Sørensen L.

· 2024-10-10

DOI: 10.1101/2024.10.10.24315225

Impacts on study design when implementing digital measures in Parkinson's disease-modifying therapy trials.

Lavine JS, Scotina AD, Haney S, Bakker JP, Izmailova ES, Omberg L.

Front Digit Health · 2024-10-09

DOI: 10.3389/fdgth.2024.1430994PMID: 39445101

Improvements in clinical signs and symptoms of Parkinson's disease using photobiomodulation: a five-year follow-up.

Liebert A, Bicknell B, Laakso EL, Tilley S, Heller G, Kiat H, Herkes G.

BMC Neurol · 2024-10-09

DOI: 10.1186/s12883-024-03857-zPMID: 39385144

Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.

Pagano G, Monnet A, Reyes A, Ribba B, Svoboda H, Kustermann T, Simuni T, Postuma RB, Pavese N, Stocchi F, Brockmann K, Smigorski K, Gerbaldo V, Fontoura P, Doody R, Kerchner GA, Brundin P, Marek K, Bonni A, Nikolcheva T, PASADENA Investigators, Prasinezumab Study Group.

Nat Med · 2024-10-08

DOI: 10.1038/s41591-024-03270-6PMID: 39379705

Targeting Neurological Disorders with Stilbenes: Bridging the Preclinical-Clinical Gap.

Begh MZA, Khan J, Zehravi M, Sweilam SH, Raja AD, Muthukumar A, Haque MA, Kar NR, Singh LP, Priya BD, Alshehri MA, Ahmad I, Kang S, Moon S, Park MN, Emran TB, Kim B.

Int J Biol Sci · 2024-10-07

DOI: 10.7150/ijbs.102032PMID: 39494329

12492 Clinical Resolution Of Parkinsonism And Dementia Following Radio Frequency Ablation Of A Parathyroid Adenoma

Check source for author details

Journal of the Endocrine Society · 2024-10-05